GILD

Gilead Sciences, Inc. News Headlines

$104.83
*  
0.65
0.62%
Get GILD Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Stock of the Week: Gilead Sciences (GILD)
10/27/2014 7:24:31 AM - Marc Chaikin


3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
10/27/2014 7:03:02 AM - Motley Fool


How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple Infographic
10/26/2014 10:15:02 AM - Motley Fool


Cramer's Mad Money - Declaring Victory In Palo Alto Networks (10/24/14)
10/26/2014 6:12:00 AM - Seeking Alpha


Stocks Trade Higher Ahead of News-Heavy Weekend
10/24/2014 3:13:00 PM - Minyanville


Friday's ETF with Unusual Volume: BBH
10/24/2014 2:47:15 PM - BNK Invest


Will Gilead (GILD) Miss Earnings on High Operating Costs? - Analyst Blog
10/24/2014 2:39:00 PM - Zacks.com


Fab Four - Got To Get You Into My Life
10/24/2014 1:24:00 PM - Seeking Alpha


5 Things Johnson & Johnson's Management Wants You to Know
10/24/2014 9:31:03 AM - Motley Fool


Biotech Breakout: Technical Analysis And Major News
10/24/2014 8:49:00 AM - Seeking Alpha


Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street
10/24/2014 8:04:03 AM - Motley Fool


Regulus Therapeutics' RG-101 Poses Liver Cancer Risk
10/23/2014 11:03:00 AM - Seeking Alpha


Gilead's Hep C Dream Drug Faces Demanding Investors
10/22/2014 3:44:00 PM - Investor's Business Daily


Why Regulus Therapeutics Inc. Stock More Than Doubled
10/22/2014 2:46:21 PM - Motley Fool


Is Johnson & Johnson's Worst Nightmare Becoming Reality?
10/22/2014 7:39:02 AM - Motley Fool


Gilead Sciences: Pricing, Politics And Profits
10/21/2014 3:23:00 PM - Seeking Alpha


5 Best Biotech Stocks to Buy Now
10/21/2014 9:33:02 AM - InvestorPlace Media


Gilead Sciences: Clear The Dockets And Settle With Merck Already
10/21/2014 9:07:00 AM - Seeking Alpha


3 Drugs Critical to Johnson & Johnson's Future
10/21/2014 7:26:02 AM - Motley Fool


3 Stocks I'll Buy if the Market Crashes
10/20/2014 12:01:02 PM - Motley Fool


Gilead: Stage Set For Rally
10/20/2014 8:27:00 AM - Seeking Alpha


End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies
10/20/2014 7:40:00 AM - Seeking Alpha


What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
10/20/2014 7:15:02 AM - Motley Fool


This Drug Could Outsell Medical Marijuana
10/19/2014 11:02:02 AM - Motley Fool


180 Million People Have This Disease, Yet Few Are Aware of It
10/19/2014 6:47:02 AM - Motley Fool